185 results
Page 4 of 10
S-8 POS
96zz13j016 7r25ruzoo
9 Aug 21
Registration of securities for employees (post-effective amendment)
5:23pm
S-8 POS
h8whcdv8jsbt olxeh7s
9 Aug 21
Registration of securities for employees (post-effective amendment)
5:23pm
S-8 POS
EX-23.2
t93 007j084s
9 Aug 21
Registration of securities for employees (post-effective amendment)
5:23pm
S-8 POS
7u70loj 33d3ni0ftth5
9 Aug 21
Registration of securities for employees (post-effective amendment)
5:23pm
S-8 POS
EX-23.2
a4ks5
9 Aug 21
Registration of securities for employees (post-effective amendment)
5:23pm
S-8 POS
rcr h9pylc
9 Aug 21
Registration of securities for employees (post-effective amendment)
5:22pm
S-8 POS
EX-23.2
72mqti
9 Aug 21
Registration of securities for employees (post-effective amendment)
5:22pm
S-8
EX-23.2
1pe0ua3qe75c
9 Aug 21
Registration of securities for employees
4:56pm
S-8
1p1aitt h13e
9 Aug 21
Registration of securities for employees
4:56pm
8-K
EX-1.1
f5esgyjktrmx gqt
9 Aug 21
Entry into a Material Definitive Agreement
4:48pm
424B5
pkjdduj
9 Aug 21
Prospectus supplement for primary offering
4:43pm
8-K
vvf7sqzl
22 Jul 21
Ocular Therapeutix™ Announces Second Quarter 2021 Preliminary Net Product Revenue of $11.7 Million
4:33pm
8-K
jk0 yjisudo
22 Jun 21
Departure of Directors or Certain Officers
4:14pm
8-K
EX-10.1
r3q84lxqh88y
4 Jun 21
Entry into a Material Definitive Agreement
4:34pm
DEFA14A
nadsd1kxoa424kuiz0pb
29 Apr 21
Additional proxy soliciting materials
4:18pm
8-K
feodl5c
29 Apr 21
Results of Operations and Financial Condition
6:31am